Search

Zoetis Inc

Gesloten

SectorGezondheidszorg

72.59 -1.51

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

70.98

Max

73.68

Belangrijke statistieken

By Trading Economics

Inkomsten

90M

691M

Verkoop

206M

2.5B

K/W

Sectorgemiddelde

11.84

57.002

EPS

1.87

Dividendrendement

2.84

Winstmarge

27.998

Werknemers

14,500

EBITDA

-12M

927M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+24.23% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

2.84%

2.22%

Volgende Winsten

3 nov 2026

Volgende dividenddatum

1 sep 2026

Volgende Ex Dividend datum

30 okt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-1.5B

31B

Vorige openingsprijs

74.1

Vorige sluitingsprijs

72.59

Nieuwssentiment

By Acuity

48%

52%

142 / 340 Rangschikking in Healthcare

Zoetis Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

14 aug 2026, 23:06 UTC

Zoetis Inc. shares are higher in after-market trading, recovering from earlier losses. This movement occurs amid broader economic concerns over declining U.S. retail sales.

13 aug 2026, 23:06 UTC

Zoetis Inc. shares moved lower in after-market trading, reflecting a modest decline since Thursday's close. The performance remains within the one-month trading range.

12 aug 2026, 20:01 UTC

News

Zoetis Inc. shares are lower as analysts cut price targets amid broader market pressures. Piper Sandler lowered its target from $90 to $80.

11 aug 2026, 23:36 UTC

Zoetis Inc. shares traded roughly flat in after-market hours, showing minimal change and stability within the middle of its one-month trading range.

10 aug 2026, 23:06 UTC

Correlated Moves
News

Shares of Zoetis Inc. are higher in after-market trading as investor Michael Burry increases his long equity position, citing potential for multi-year stabilization.

8 aug 2026, 00:01 UTC

Zoetis Inc. shares are higher in after-market trading, reflecting gains since Friday's close amid broader market dynamics influenced by recent economic data.

7 aug 2026, 23:01 UTC

Zoetis shares advanced in after-market trading, showing notable activity despite being below the 20-day moving average and near the lower end of its one-month range.

6 aug 2026, 23:26 UTC

News

Zoetis Inc shows a modest advance in after-market trading, now valued at approximately $31.19 billion, ranking as the 298th largest firm by market capitalization.

5 aug 2026, 23:41 UTC

Zoetis Inc. shares declined in after-market trading, remaining below their 20-day moving average despite earlier gains. Asian markets, including the Nikkei 225, performed positively.

4 aug 2026, 19:26 UTC

Zoetis Inc shares are lower today amid unusual volatility, reaching a session low earlier. No specific news was identified to explain the movement.

3 aug 2026, 23:31 UTC

Zoetis Inc shares are higher in after-market trading, continuing positive momentum after three consecutive sessions of gains amid favorable market sentiment.

1 aug 2026, 00:01 UTC

Zoetis Inc shares rose in after-market trading, recovering from an initial dip and reaching a high near the upper end of its one-month range.

31 jul 2026, 23:06 UTC

Zoetis Inc shares are higher in after-market trading, maintaining gains since Friday's close and remaining above the 20-day moving average.

30 jul 2026, 19:03 UTC

Zoetis Inc shares are lower, impacted by a decline in the Pharmaceuticals sub-sector. Earlier in the session, the stock peaked before falling.

29 jul 2026, 22:51 UTC

Zoetis Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline amid broader market volatility.

28 jul 2026, 23:02 UTC

Zoetis Inc shares are higher in after-market trading, reflecting broader market strength amid investor optimism ahead of key earnings reports and the Federal Reserve meeting.

27 jul 2026, 23:16 UTC

News

Zoetis shares are lower in after-market hours following a class action lawsuit alleging securities fraud and reduced profit guidance to between $6.85 and $7.00 per share.

25 jul 2026, 00:01 UTC

Zoetis Inc. shares are trading higher in after-market hours, continuing a positive trend after closing higher for three consecutive sessions.

24 jul 2026, 21:02 UTC

Zoetis Inc shares are higher in after-market trading, rebounding from an initial dip despite a broader market decline influenced by disappointing earnings from Tesla and Alphabet.

23 jul 2026, 20:02 UTC

Zoetis Inc. shares are higher as strength in the pharmaceuticals sub-sector drives upward momentum, contributing to modest gains since Wednesday's close.

22 jul 2026, 21:02 UTC

Zoetis Inc. shares are lower in after-market trading, continuing a trend of five consecutive daily declines amid mixed market performance and rising crude oil prices.

21 jul 2026, 17:51 UTC

News

Zoetis Inc. shares are lower amid scrutiny from a securities fraud class action lawsuit alleging undisclosed market share declines and safety issues with Librela.

20 jul 2026, 23:16 UTC

Zoetis shares traded higher in after-market hours, maintaining stability above Monday's close despite broader market pressures from rising treasury yields.

Peer Vergelijking

Prijswijziging

Zoetis Inc Prognose

Koersdoel

By TipRanks

24.23% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 91.67 USD  24.23%

Hoogste 115 USD

Laagste 80 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor Zoetis Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

12 ratings

5

Buy

7

Hold

0

Sell

Sentiment

By Acuity

142 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat